PubPeer Threatened with Legal Action

The moderators of the post-publication peer review forum say they could be facing their first legal case.

Written byKate Yandell
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, BRIAN TURNERPubPeer, the post-publication peer review forum in which users can anonymously point out alleged flaws in the published scientific literature, has “recently received a legal threat,” according to a comment published by the site’s moderators yesterday (August 18).

The news came as a reply explaining to an anonymous academic user of the site why his or her discussion topics had been disabled. The moderators—who themselves remain anonymous—said they had recently disabled topics focused on specific groups of people.

“Although [the threat] is unrelated to your posts, we have decided that ‘personal’ topics are quite likely to attract further legal activity,” the moderators wrote. “As a matter of strategy and out of respect for those helping us with legal issues, we think it would be prudent to work through the issues of our first legal case without having to fight on several fronts at once.”

The nature of the reported legal threat to PubPeer remains unclear. In an e-mail to The Scientist, those behind ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies